BEAM THERAPEUTICS INC. - COMMON STOCK
26.53
11-February-25 14:41:45
15 minutes delayed
Stocks
-0.04
-0.15%
Today's range
25.35 - 26.57
ISIN
N/A
Source
NASDAQ
-
23 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
08 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
10 Aug 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference
03 Aug 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus Conference
08 Jul 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
25 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
11 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
27 Apr 2021 16:41:11 By Nasdaq GlobeNewswire
-
20 Apr 2021 10:12:36 By Nasdaq GlobeNewswire
-
15 Mar 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Appoints Amy Simon, M.D., Chief Medical Officer
15 Mar 2021 06:15:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Participate in the Barclays 2021 Global Healthcare Conference
04 Mar 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Announces Acquisition of Guide Therapeutics
23 Feb 2021 08:34:34 By Nasdaq GlobeNewswire
-
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
19 Jan 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors
11 Jan 2021 06:30:00 By Nasdaq GlobeNewswire
-
Beam Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 06:30:00 By Nasdaq GlobeNewswire